| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0091-3057(98)00132-4 |
| P8608 | Fatcat ID | release_mkus7kv2rzcizglgcxtq57a5ai |
| P698 | PubMed publication ID | 9972847 |
| P2093 | author name string | J Sagen | |
| U Herzberg | |||
| A T Hama | |||
| J B Siegan | |||
| P2860 | cites work | A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 |
| Activity-dependent neuronal plasticity following tissue injury and inflammation | Q35315392 | ||
| Molecular biology of pain | Q40424050 | ||
| Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence | Q40485751 | ||
| Nitric oxide (NO) and nociceptive processing in the spinal cord | Q40887811 | ||
| Attenuation of pain-related hyperventilation in adjuvant arthritic rats with adrenal medullary transplants in the spinal subarachnoid space | Q42520274 | ||
| NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride | Q42554953 | ||
| Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy | Q43547058 | ||
| Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex | Q43805603 | ||
| Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. | Q45267214 | ||
| Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists | Q46025693 | ||
| Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats | Q46176636 | ||
| Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 | ||
| Intrathecal N-methyl-D-aspartate (NMDA) activates both nociceptive and antinociceptive systems | Q48205204 | ||
| NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin | Q48250425 | ||
| Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity | Q48284565 | ||
| MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy | Q48690138 | ||
| Suppression of neuropathic pain by a naturally-derived peptide with NMDA antagonist activity | Q48708586 | ||
| Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-D-aspartate receptors and protein kinase C and production of nitric oxide. | Q50751307 | ||
| Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. | Q51644389 | ||
| Ketamine hydrochloride in the treatment of phantom limb pain. | Q51659607 | ||
| The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. | Q51685152 | ||
| The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests. | Q52509732 | ||
| Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice. | Q52510894 | ||
| Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. | Q53756167 | ||
| Central neural mediators of secondary hyperalgesia following heat injury in rats: Neuropeptides and excitatory amino acids | Q67649457 | ||
| Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transection, and strychnine | Q68614281 | ||
| Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model | Q71659962 | ||
| Synthesis and biological activity of histogranin and related peptides | Q71916516 | ||
| Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants | Q72033041 | ||
| The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats | Q72049202 | ||
| N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin | Q72120403 | ||
| NMDA receptor antagonists attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw | Q72665928 | ||
| Characterization of the role of spinal N-methyl-D-aspartate receptors in thermal nociception in the rat | Q72669739 | ||
| Neuropathic pain sensations are differentially sensitive to dextrorphan | Q72776016 | ||
| Role of excitatory amino acid receptors in the mediation of the nociceptive response to formalin in the rat | Q72830126 | ||
| Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy | Q72959685 | ||
| Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space | Q73337729 | ||
| A natural peptide with NMDA inhibitory activity reduces tonic pain in the formalin model | Q73388990 | ||
| Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats | Q73452402 | ||
| Adrenal medullary transplants attenuate sensorimotor dysfunction in rats with peripheral neuropathy | Q74093967 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 67-74 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | NMDA-induced spinal hypersensitivity is reduced by naturally derived peptide analog [Ser1]histogranin | |
| P478 | volume | 62 |
| Q35923194 | Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain |
| Q44264983 | Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats |
| Q47131605 | Experimental Gene Therapy with Serine-Histogranin and Endomorphin 1 for the Treatment of Chronic Neuropathic Pain. |
| Q35935245 | Inhibition by the chromaffin cell-derived peptide serine-histogranin in the rat's dorsal horn |
| Q31911202 | Interactions of histogranin and related peptides with dopamine D2 receptor in rat brain membranes |
| Q44567457 | Nociceptive effects of intrathecal administration of sulphur-containing amino acids |
| Q44334072 | Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: possible involvement of central dopamine D(2) receptor |
| Q37078246 | Recombinant neural progenitor transplants in the spinal dorsal horn alleviate chronic central neuropathic pain |
| Q39975879 | Sustained analgesic peptide secretion and cell labeling using a novel genetic modification |
| Q34120824 | The alleviation of pain by cell transplantation |
| Q38922658 | Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats. |
Search more.